This is confirmation of previous results as well a
Post# of 148158
“Other cancer-associated macrophage-like (CAML) cells in the blood sample were found at the lower limits of detection and were also decreased in size. Most importantly, the CAML cells had reduced CCR5 staining compared to samples taken from the patient three weeks earlier, reflecting an ongoing blockade of the CCR5 receptor by leronlimab.”
IMHO, this is just as important as the suppression of CTC in controlling metastasis.